Register entry

UroGen Pharma, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
2
Labeller names
2
Live patents
7
Exclusivities
2
Countries
0
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.

Dosage formNDCs
kit2
RouteNDCs
Labeller name on the listingNDCs
urogen pharma, inc1
urogen pharma, inc.1
Exclusivity

Patents and exclusivities

7
PatentProductCoversExpiry
10039832ZUSDURImitomycinuseJan 2031
12268745JELMYTOmitomycinuseJan 2031
12440568ZUSDURImitomycinuseJan 2031
9040074JELMYTO, ZUSDURImitomycinproductJan 2031
9950069JELMYTO, ZUSDURImitomycinproductJan 2031
ProductExclusivityUntil
JELMYTOMITOMYCINODE-289 Orphan drugApr 2027
ZUSDURIMITOMYCINNP New productJun 2028
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
JELMYTOmitomycinkit72493-103NDA
ZUSDURIMitomycinkit72493-106NDA
Compare

Other companies listing mitomycin

Enquiry

Common questions

Is UroGen Pharma, Inc. FDA approved?
UroGen Pharma, Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does UroGen Pharma, Inc. make?
2 products are listed under UroGen Pharma, Inc. in the openFDA NDC Directory, most often as kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.